XML 26 R2.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 319,526 $ 602,359
Accounts receivables, net 167,417 246,191
Inventories 139,079 161,263
Other current assets 14,027 13,923
Total current assets 640,049 1,023,736
Property, plant and equipment, net 567,024 624,959
Goodwill and intangible assets, net 256,146 25,210
Other assets 124,842 52,933
Total assets 1,588,061 1,726,838
Current liabilities:    
Short-term debt 276 7,321
Accounts payable 16,081 12,784
Deferred revenue 18,072 57,637
Accrued and other current liabilities 64,950 111,884
Total current liabilities 99,379 189,626
Deferred tax liabilities 20,951 40,257
Other non-current liabilities 156,412 44,824
Total liabilities 276,742 274,707
Commitments and contingencies
Series A preferred stock, €0.01 par value, no shares authorized, issued or outstanding at 2016; 52,976,000 shares authorized, issued and outstanding at 2015 0 705
Stockholders' equity    
Common stock, €0.01 par value, 798,096,000 shares authorized, 223,161,356 shares issued and 222,401,427 shares outstanding at December 31, 2016 and 745,120,000 shares authorized, 155,661,150 shares issued and 155,146,338 shares outstanding at December 31, 2015 2,802 2,045
Additional paid-in capital 1,036,786 712,486
Retained earnings 317,270 531,621
Accumulated other comprehensive loss (32,977) (25,555)
Treasury shares (at cost), 759,929 and 514,812 at December 31, 2016 and 2015, respectively (12,562) (9,298)
Total stockholders' equity 1,311,319 1,211,299
Noncontrolling interest 0 240,127
Total equity 1,311,319 1,451,426
Total liabilities and equity $ 1,588,061 $ 1,726,838